ALXN
Price:
$182.5
Market Cap:
$0
Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company offers ULTOMIRIS (ALXN1210/ravulizumab-cwvz), a C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS); and SOLIRIS (eculizumab), a monoclonal antibody for the treatment of PNH, aHUS, generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It also provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosphatasia; and Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency. In addition, the company is developing ALXN12...[Read more]
Industry
Biotechnology
IPO Date
1996-02-01
Stock Exchange
NASDAQ
Ticker
ALXN
According to Alexion Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 5.26%. This represents a change of 342.46% compared to the average of 1.19% of the last 4 quarters.
The mean historical ROE of Alexion Pharmaceuticals, Inc. over the last ten years is 9.76%. The current 5.26% ROE has changed -46.04% with respect to the historical average. Over the past ten years (40 quarters), ALXN's ROE was at its highest in in the December 2019 quarter at 7.89%. The ROE was at its lowest in in the June 2020 quarter at -10.18%.
Average
9.76%
Median
7.90%
Minimum
0.85%
Maximum
21.33%
Discovering the peaks and valleys of Alexion Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.42%
Maximum Annual ROE = 21.33%
Minimum Annual Increase = -91.21%
Minimum Annual ROE = 0.85%
| Year | ROE | Change |
|---|---|---|
| 2020 | 5.18% | -75.72% |
| 2019 | 21.33% | 2.42% |
| 2018 | 0.85% | -83.01% |
| 2017 | 4.98% | 8.62% |
| 2016 | 4.59% | 162.51% |
| 2015 | 1.75% | -91.21% |
| 2014 | 19.89% | 87.39% |
| 2013 | 10.62% | -17.89% |
| 2012 | 12.93% | -16.33% |
| 2011 | 15.45% | 36.92% |
The current ROE of Alexion Pharmaceuticals, Inc. (ALXN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.12%
5-year avg
7.39%
10-year avg
9.76%
Alexion Pharmaceuticals, Inc.’s ROE is greater than Seagen Inc. (-20.80%), greater than Ambrx Biopharma Inc. (-50.68%), less than Odonate Therapeutics, Inc. (7.01%), greater than La Jolla Pharmaceutical Company (-25.40%), less than Niagen Bioscience Inc (35.46%), greater than Roivant Sciences Ltd. (-8.05%), less than Takara Bio Inc. (0.52%), greater than Arena Pharmaceuticals, Inc. (-70.77%), less than EQRx, Inc. (14.15%), less than POINT Biopharma Global Inc. (26.49%),
| Company | ROE | Market cap |
|---|---|---|
| -20.80% | $43.15B | |
| -50.68% | $1.77B | |
| 7.01% | $24.14B | |
| -25.40% | $0 | |
| 35.46% | $521.13M | |
| -8.05% | $15.37B | |
| 0.52% | $2.79B | |
| -70.77% | $0 | |
| 14.15% | $1.14B | |
| 26.49% | $1.33B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alexion Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alexion Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Alexion Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Alexion Pharmaceuticals, Inc. (ALXN)?
What is the highest ROE for Alexion Pharmaceuticals, Inc. (ALXN)?
What is the 3-year average ROE for Alexion Pharmaceuticals, Inc. (ALXN)?
What is the 5-year average ROE for Alexion Pharmaceuticals, Inc. (ALXN)?
How does the current ROE for Alexion Pharmaceuticals, Inc. (ALXN) compare to its historical average?